AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.2483
+0.0083 (3.46%)
At close: Oct 27, 2026, 4:00 PM EDT
0.2436
-0.0047 (-1.89%)
After-hours: Oct 27, 2026, 4:24 PM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $12.39 million as of October 27, 2026. It is the 40,387th most valuable company in the world and the 5,502nd biggest in the United States. Its market cap has increased by 13.16% in one year.
Market Cap
12.39M
Enterprise Value
11.73M
1-Year Change
13.16%
Global Rank
Country Rank
#5,502 United States
Category
ChartMarket Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $12.39M, a decrease of -80.54%. That is a compound annual growth rate of -25.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 12.39M | -4.89% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daré Bioscience | 12.70M |
| SeaStar Medical Holding | 12.68M |
| Vyome Holdings | 12.56M |
| Tvardi Therapeutics | 12.54M |
| Cerenome | 12.45M |
| Pluri | 12.22M |
| Bolt Biotherapeutics | 12.08M |
| Lipocine | 11.87M |